Canaccord analyst Susan Anderson reiterated a Buy rating and $10.00 price target on (NASDAQ: NAGE).The analyst commented: "Niagen Bioscience announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments